Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 23Terminated 9Active not recruiting 6Unknown 3Recruiting 3Withdrawn 1Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2Sarcoma 1

Conditions

Melanoma 2Sarcoma, Kaposi 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × talimogene laherparepvec × Clear all
NCT04065152 2022-06-10

KAPVEC

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown
20 enrolled
Sarcoma

Sarcoma, Kaposi

NCT03747744 2020-12-29

myDCTV

Universitair Ziekenhuis Brussel

Phase 1 Unknown
18 enrolled
Dermatologic

Melanoma

NCT03088176 2020-10-12

Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma

West Cancer Center

Phase 1 Unknown
4 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡